Asian participants' experience in phase 3/3b studies of long-acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96-论文-万方医学网

首页> > Asian participants' experience in phase 3/3b studies of long-acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96

Asian participants' experience in phase 3/3b studies of long-acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96

导出原文传递

翻译打印收藏纠错

第一作者： Oka, Shinichi

作者： Oka, Shinichi ^[1] ; Holohan, Vicki ^[2] ; Shirasaka, Takuma ^[3] ; Choi, Jun Yong ^[4] ; Kim, Yeon-Sook ^[5] ; Chamay, Nadine ; Patel, Parul ; Polli, Joseph W. ; Ford, Susan L. ; Crauwels, Herta ; Garside, Louise ; D'Amico, Ronald ; Latham, Christine ; van Solingen-Ristea, Rodica ; Baugh, Bryan ; van Wyk, Jean

作者单位： GlobalHlth ConsultantUniv Hosp Bonn University of Bonn Dept Med 1 Univ Hosp Bonn University of Bonn ^[1] PHASTAR ^[2] PHASTARViiV Healthcare GlaxoSmithKline ^[3] PHASTARViiV Healthcare GlaxoSmithKline ViiV Healthcare GlaxoSmithKline ^[4] PHASTARViiV Healthcare GlaxoSmithKline ViiV Healthcare GlaxoSmithKline Janssen Res & Dev Johnson & ^[5]

关键词 antiretroviral therapy cabotegravir HIV-1 long-acting rilpivirine ADULTS HIV

发布时间 2024-04-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Asian participants' experience in phase 3/3b studies of long-acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96

相似文献

同项目论文

相关期刊

检索历史 清除

Asian participants' experience in phase 3/3b studies of long-acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96

相似文献

同项目论文

相关期刊

检索历史清除